Premium
Surgery is not superior to octreotide LAR in newly diagnosed patients with acromegaly
Author(s) -
Colao Annamaria
Publication year - 2010
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2009.03770.x
Subject(s) - acromegaly , octreotide , medicine , randomized controlled trial , pediatric endocrinology , clinical trial , medline , endocrinology , somatostatin , hormone , growth hormone , political science , law